![Arthur M. Krieg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur M. Krieg
Plus aucun poste en cours
Profil
Arthur M.
Krieg is the founder of Coley Pharmaceutical Group, Inc. (founded in 1997), Translate Bio, Inc. (founded in 2011), and Checkmate Pharmaceuticals, Inc. (founded in 2015).
At Coley Pharmaceutical Group, Inc., he held the title of Chief Scientific Officer & Senior Vice President from 1997 to 2011.
At Translate Bio, Inc., he held the title of Chief Executive Officer from 2011 to 2013.
At Checkmate Pharmaceuticals, Inc., he held the titles of CEO, Director & Chief Scientific Officer from 2015 to 2018.
Dr. Krieg's former jobs included Chief Executive Officer at Translate Bio, Inc. from 2011 to 2014, Director at Cytos Biotechnology AG from 2012 to 2014, Chief Scientific Officer & Senior Vice President at Sarepta Therapeutics, Inc. in 2014, Professor at the University of Iowa, and Chief Scientific Officer at Oligonucleotide Therapeutics Society, Inc. from 2008 to 2011.
Dr. Krieg's education includes a doctorate from the University of Washington and an undergraduate degree from Haverford College.
Anciens postes connus de Arthur M. Krieg
| Sociétés | Poste | Fin |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Directeur Général | 12/12/2018 |
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 22/07/2014 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Directeur/Membre du Conseil | 31/05/2014 |
| TRANSLATE BIO, INC. | Directeur Général | 01/01/2014 |
| TRANSLATE BIO, INC. | Directeur Général | 01/01/2013 |
Formation de Arthur M. Krieg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
National Institute of Arthritis
 National Institute of Arthritis General GovernmentGovernment Operates musculoskeletal and skin disease research centers | Government |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
